Compass Therapeutics Cash Flow Statement (2022-2026) | CMPX

Cash Flow Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -7.84M-11.28M-9.96M-13.41M-10.79M-13.08M-12.24M-16.57M-16.63M-21.07M-15.82M-17.99M-20.30M
Depreciation and Depletion (Quarter) 0.20M0.20M0.10M0.20M0.20M0.10M0.20M0.10M0.14M0.06M0.10M0.01M
Share-based Compensation (Quarter) 1.27M1.63M1.62M1.60M2.00M2.12M2.20M2.24M2.51M2.79M1.24M1.82M5.07M
Gains from Sales and Divestitures (Quarter) 0.30M0.30M0.23M0.23M0.23M0.53M0.82M0.82M0.82M1.07M0.28M
Gains from Investment Securities (Quarter) 5.38M7.75M7.76M0.04M5.75M0.10M0.81M4.48M17.16M0.40M
Non-cash Items (Quarter) 6.32M11.30M10.40M0.01M0.63M11.40M1.80M0.58M21.50M19.50M11.62M36.61M32.47M
Cash from Operations (Quarter) -12.23M-10.11M-5.92M-12.35M-13.89M-10.75M-11.05M-9.16M-13.21M-11.83M-10.85M-13.25M-17.27M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.29M0.29M0.30M0.31M0.31M0.31M0.32M0.22M0.22M0.27M0.35M0.35M0.35M
Amortization of Deferred Charges (Quarter) -0.59M-1.03M-0.79M-0.81M-0.38M-0.73M-0.28M-0.27M0.03M-0.13M-0.38M-1.20M-0.21M
Depreciation & Amortization (CF) (Quarter) 0.19M0.18M0.16M0.16M0.15M0.15M0.14M0.14M0.14M0.10M0.02M0.02M0.01M
Change in Working Capital
Change in Account Payables (Quarter) -2.26M-0.40M1.58M1.78M-3.24M0.34M-0.23M1.29M-0.67M1.02M0.50M-1.51M-0.68M
Change in Accured Expenses (Quarter) -2.75M-1.12M-2.18M-3.13M-0.70M5.41M-4.31M3.37M6.93M-2.22M-2.31M2.70M-3.38M
Other Working Capital Changes (Quarter) 0.25M-0.84M-4.71M4.10M0.94M4.96M-6.54M-0.58M-0.25M-0.04M-0.04M-4.79M0.09M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.01M0.01M0.04M0.02M0.01M0.08M
Change in Acquisitions & Divestments (Quarter) 59.19M37.39M34.43M51.40M37.78M37.55M34.41M25.23M36.44M26.81M13.93M24.10M83.33M
Cash from Investing Activities (Quarter) 4.27M-0.67M17.05M6.31M-4.10M6.48M29.02M15.37M11.59M-6.36M-95.16M-3.38M38.43M
Financing Activities
Other financing activities (Quarter) -0.25M-0.14M0.68M0.00M-0.00M-0.81M0.81M8.64M-0.49M
Cash from Financing Activities (Quarter) 0.04M3.03M0.02M-0.16M17.43M0.00M-0.00M-0.09M-0.81M129.36M1.06M3.37M
Additional items
Change in Cash (Quarter) -7.92M-7.75M11.15M-6.20M-0.55M-4.27M17.96M6.11M-2.44M-18.19M23.36M-15.57M24.52M
Free Cash Flow (Quarter) -12.23M-10.12M-5.93M-12.36M-13.89M-10.75M-11.10M-9.16M-13.23M-11.83M-10.86M-13.25M-17.35M
Net Cash Flow (Quarter) -7.92M-7.75M11.15M-6.20M-0.55M-4.27M17.96M6.11M-2.44M-18.19M23.36M-15.57M24.52M